Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

about

Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

Item

http://www.wikidata.org/entity/Q47685928

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

@en

Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

@nl

type

Item

label

Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

@en

Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

@nl

prefLabel

Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

@en

Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

@nl

P1476

Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients.

@en

P2093

Caroline Lum

http://www.w3.org/2001/XMLSchema#string

P2860

Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?

Elderly patients' participation in clinical trials

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

Integrated genomic analyses of ovarian carcinoma

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Cancer statistics, 2016

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO).

Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer.

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

P2888

s40266-017-0495-1

P304

821-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40266-017-0495-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Steer

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29086349

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer